OTC : CNBX
$0 (0.0%)
%
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
-
-
change: 0.0 | last:
-
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-08 | 3i, LP | 124.95M | 9.90% |
| 2026-02-05 | 3i, LP | 83.6M | 9.90% |
| 2025-11-10 | 3i, LP | 80.87M | 9.90% |
| 2025-08-13 | 3i, LP | 13.57M | 9.90% |
| 2025-05-13 | 3i, LP | 3.42M | 9.90% |
| 2025-02-13 | 3i, LP | 3.41M | 9.90% |
| 2023-03-06 | S | 238.98K | 9.98% |
| 2023-03-06 | S | 238.98K | 9.98% |
| 2023-03-06 | S | 238.98K | 9.98% |
| 2019-03-27 | Cannabics Pharmaceuticals, Inc. | 900K | 9.60% |
| 2014-06-25 | Cannabics, Inc. | 20.5M | 51.00% |
| 2014-05-01 | Thomas Mills | - | 0.00% |
| 2013-11-04 | Thomas Mills | 20.5M | 99.10% |
| 2013-10-29 | Thomas Mills | 20.51M | 99.10% |
| 2013-07-03 | Ophion Management Ltd. | 20M | 99.00% |
| 2013-07-03 | Thomas Mills | 20.51M | 99.00% |
| 2013-06-28 | Ophion Management Ltd. | 20M | 99.00% |
| 2013-06-28 | Thomas Mills | 20.51M | 99.00% |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-08-31 | $0.00 | 90.65M | $45324.74 | $15111 | $1.2M | $1.23M |
| 2024-08-31 | $0.01 | 30.25M | $187.54K | $26416 | $1.3M | $1.46M |
| 2023-08-31 | $0.02 | 8.82M | $149.14K | $129.7K | $1.34M | $1.36M |
| 2022-08-31 | $3.40 | 1.22M | $4.16M | $117.52K | $1.76M | $5.8M |
| 2021-08-31 | $20.40 | 1.15M | $23.54M | $1.39M | $871.9K | $23.03M |
| 2020-08-31 | $22.92 | 1.12M | $25.69M | $777.61K | -$ | $24.92M |
| 2019-08-31 | $31.20 | 1.1M | $34.44M | $265.98K | -$ | $34.18M |
| 2018-08-31 | $109.20 | 1M | $109.54M | $1.39M | -$ | $108.15M |
| 2017-08-31 | $122.40 | 919.8K | $112.58M | $3.37M | -$ | $109.22M |
| 2016-08-31 | $5.98 | 860.45K | $5.15M | $19127 | -$ | $5.13M |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-05-31 | $0.00 | 1.32B | $242.62K | $9487 | $120K | $353.13K |
| 2026-02-28 | $0.00 | 931.02M | $186.2K | $12154 | $75000 | $249.05K |
| 2025-11-30 | $0.00 | 732.86M | $219.86K | $7703 | $1.25M | $1.46M |
| 2025-08-31 | $0.00 | 553.96M | $276.98K | $15111 | $1.2M | $1.46M |
| 2025-05-31 | $0.00 | 42.6M | $57506.48 | $13648 | $1.34M | $1.38M |
| 2025-02-28 | $0.01 | 32.1M | $320.97K | $45675 | $1.4M | $1.67M |
| 2024-11-30 | $0.01 | 31.11M | $233.34K | $17339 | $1.33M | $1.54M |
| 2024-08-31 | $0.01 | 31.11M | $192.89K | $26416 | $1.3M | $1.46M |
| 2024-05-31 | $0.01 | 31.11M | $280K | $73406 | $1.29M | $1.5M |
| 2024-02-29 | $0.01 | 30.99M | $371.86K | $37142 | $1.29M | $1.63M |
| 2023-11-30 | $0.01 | 27.76M | $333.13K | $81647 | $1.31M | $1.57M |
| 2023-08-31 | $0.02 | 22.61M | $382.12K | $129.7K | $1.34M | $1.6M |